Diagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies

Overview

Journal Indian J Surg Oncol

Specialty Oncology

Date 2016 Apr 12

PMID 27065714

Citations 12

Authors

Ramakrishnan Ayloor Seshadri

Hemanth Raj E

Affiliations

Soon will be listed here.

Abstract

The introduction of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has led to an improvement in the survival of select patients with peritoneal surface malignancies (PSM). However, it is important to carefully identify patients who will benefit from this procedure and to avoid an unnecessary laparotomy in those who will not. The currently available imaging modalities are unable to accurately predict the peritoneal cancer index (PCI) score or the completeness of cytoreduction. In this article, we review the current status of staging laparoscopy in the assessment of patients with PSM who are planned for CRS & HIPEC. We discuss the patient selection, techniques, complications and efficacy of staging laparoscopy. To summarise, staging laparoscopy is a safe and feasible method of pre-operative assessment of patients with PSM. It has a high sensitivity and positive predictive value in identifying patients who can undergo a complete cytoreduction, thereby preventing many patients from undergoing an unnecessary laparotomy. With the exception of pseudomyxoma peritonei, it should be considered as a part of the routine assessment of patients with PSM who are being considered for CRS & HIPEC.

Citing Articles

The CEA/PCI ratio is a superior prognosticator than mCOREP for colorectal cancer patients with peritoneal carcinomatosis.

Anthony P, Barat S, Ahmadi N, Morris D Surg Open Sci. 2024; 19:28-31.

PMID: 38585035 PMC: 10995861. DOI: 10.1016/j.sopen.2024.03.014.

Malignant Peritoneal Mesothelioma: An In-Depth and Up-to-Date Review of Pathogenesis, Diagnosis, Management and Future Directions.

Karpes J, Shamavonian R, Dewhurst S, Cheng E, Wijayawardana R, Ahmadi N Cancers (Basel). 2023; 15(19).

PMID: 37835398 PMC: 10571654. DOI: 10.3390/cancers15194704.

Peritoneal Mesothelioma in a High Volume Peritoneal Surface Malignancies Unit.

Pereira F, Pereira M, Manzanedo I, Serrano A, Perez-Viejo E J Clin Med. 2023; 12(6).

PMID: 36983292 PMC: 10058502. DOI: 10.3390/jcm12062288.

Pseudomyxoma peritonei induced by a well-differentiated appendicular mucinous adenocarcinoma: An uncommon cause of isolated ascites in a young man patient.

Randriamifidy N, Ranaivoson M, Ramiandrasoa A, Razafindrazoto C, Ranaivomanana V, Hasina Laingonirina D Clin Case Rep. 2023; 11(3):e7103.

PMID: 36937631 PMC: 10014516. DOI: 10.1002/ccr3.7103.

Diagnostic and Therapeutic Algorithm for Appendiceal Tumors and Pseudomyxoma Peritonei: A Consensus of the Peritoneal Malignancies Oncoteam of the Italian Society of Surgical Oncology (SICO).

Vaira M, Robella M, Guaglio M, Berchialla P, Sommariva A, Valle M Cancers (Basel). 2023; 15(3).

PMID: 36765686 PMC: 9913318. DOI: 10.3390/cancers15030728.

References

Jayakrishnan T, Zacharias A, Sharma A, Pappas S, Clark Gamblin T, Turaga K . Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). World J Surg Oncol. 2014; 12:270. PMC: 4153918. DOI: 10.1186/1477-7819-12-270. View

Esquivel J, Elias D, Baratti D, Kusamura S, Deraco M . Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol. 2008; 98(4):263-7. DOI: 10.1002/jso.21053. View

Baratti D, Kusamura S, Mingrone E, Balestra M, Laterza B, Deraco M . Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2012; 256(2):334-41. DOI: 10.1097/SLA.0b013e31825704e3. View

Jacquet P, Jelinek J, Steves M, Sugarbaker P . Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer. 1993; 72(5):1631-6. DOI: 10.1002/1097-0142(19930901)72:5<1631::aid-cncr2820720523>3.0.co;2-i. View

Suzuki A, Kawano T, Takahashi N, Lee J, Nakagami Y, Miyagi E . Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging. 2004; 31(10):1413-20. DOI: 10.1007/s00259-004-1577-y. View

Harmon R, Sugarbaker P . Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol. 2005; 2(1):3. PMC: 549516. DOI: 10.1186/1477-7800-2-3. View

Valle M, Federici O, Garofalo A . Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment. Surg Oncol Clin N Am. 2012; 21(4):515-31. DOI: 10.1016/j.soc.2012.07.005. View

Pomel C, Appleyard T, Gouy S, Rouzier R, Elias D . The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2005; 31(5):540-3. DOI: 10.1016/j.ejso.2005.01.009. View

Bree E, Koops W, Kroger R, van Ruth S, Verwaal V, Zoetmulder F . Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2005; 32(1):65-71. DOI: 10.1016/j.ejso.2005.09.016. View

10.

Denzer U, Hoffmann S, Helmreich-Becker I, Kauczor H, Thelen M, Kanzler S . Minilaparoscopy in the diagnosis of peritoneal tumor spread: prospective controlled comparison with computed tomography. Surg Endosc. 2004; 18(7):1067-70. DOI: 10.1007/s00464-003-9139-0. View

11.

Van Sweringen H, Hanseman D, Ahmad S, Edwards M, Sussman J . Predictors of survival in patients with high-grade peritoneal metastases undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Surgery. 2012; 152(4):617-24. DOI: 10.1016/j.surg.2012.07.027. View

12.

Glehen O, Kwiatkowski F, Sugarbaker P, Elias D, Levine E, de Simone M . Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004; 22(16):3284-92. DOI: 10.1200/JCO.2004.10.012. View

13.

Mohamed F, Moran B . Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Cancer J. 2009; 15(3):196-9. DOI: 10.1097/PPO.0b013e3181a58d56. View

14.

Glehen O, Gilly F, Arvieux C, Cotte E, Boutitie F, Mansvelt B . Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010; 17(9):2370-7. DOI: 10.1245/s10434-010-1039-7. View

15.

Yonemura Y, Elnemr A, Endou Y, Hirano M, Mizumoto A, Takao N . Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol. 2010; 2(2):85-97. PMC: 2998933. DOI: 10.4251/wjgo.v2.i2.85. View

16.

Klumpp B, Schwenzer N, Aschoff P, Miller S, Kramer U, Claussen C . Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI. Abdom Imaging. 2012; 38(1):64-71. DOI: 10.1007/s00261-012-9881-7. View

17.

Tabrizian P, Jayakrishnan T, Zacharias A, Aycart S, Johnston F, Sarpel U . Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: A multi-institutional analysis. J Surg Oncol. 2015; 111(8):1035-40. DOI: 10.1002/jso.23924. View

18.

Koh J, Yan T, Glenn D, Morris D . Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2008; 16(2):327-33. DOI: 10.1245/s10434-008-0234-2. View

19.

Esquivel J, Chua T, Stojadinovic A, Torres Melero J, Levine E, Gutman M . Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol. 2010; 102(6):565-70. DOI: 10.1002/jso.21601. View

20.

Verwaal V, van Ruth S, de Bree E, van Sloothen G, van Tinteren H, Boot H . Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003; 21(20):3737-43. DOI: 10.1200/JCO.2003.04.187. View